Conserved pneumococcal protein antigens

Conserved pneumococcal protein antigens are a diverse group of proteins expressed by Streptococcus pneumoniae that remain relatively invariant across more than 90 known serotypes (Kadioglu et al., 2008). Key antigens include Pneumolysin (Ply), a cholesterol-dependent cytolysin that causes tissue damage; Pneumococcal surface protein A (PspA), which inhibits complement-mediated opsonization; and Pneumococcal surface adhesin A (PsaA), a lipoprotein involved in metal ion transport and adhesion (Pichichero, 2017). These proteins are critical for the pathogen's ability to colonize the nasopharynx, invade host tissues, and evade the immune system (Lagousi et al., 2019). Because they are conserved, they are being extensively researched as universal vaccine targets to overcome the limitations of current polysaccharide-based vaccines, which only cover a subset of serotypes and are subject to serotype replacement (Genocea Biosciences, 2015). Therapeutic strategies involve using these proteins, often in recombinant or detoxified forms, to elicit robust humoral and cellular immune responses, including Th17-mediated mucosal protection (Pichichero, 2017). Clinical candidates like GEN-004 and various multi-antigen formulations have aimed to reduce pneumococcal carriage and invasive disease by targeting these conserved structures (Genocea Biosciences, 2015).

Other names

Pneumococcal protein antigensSerotype-independent pneumococcal antigensPneumococcal surface proteinsUniversal pneumococcal vaccine antigens

Induction of neutralizing antibodies and T-cell mediated immunity (specifically Th17) to prevent bacterial colonization and systemic invasion across multiple serotypes (Pichichero, 2017).